Taken together, these experiments supported the notion that the classical PI3K-AKT-mTOR participated in the ALDH9A1-mediated tumor-suppressor and metabolic reprogramming roles in ccRCC. Here, ALDH9A1 is linked to nonpapillary renal cell carcinoma.